Oerth Bio is a agriculture-focused biotech firm.
Oerth Bio is a developer of targeted protein degraders for agricultural applications. The company leverages Arvinas' novel PROTAC protein degrader technology to develop new human therapeutics for patients with cardiovascular, oncological, and gynecological diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 27, 2020 | Corporate Round | $55M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Bayer | — | Corporate Round |